Pulmonary function trajectories in rheumatoid arthritis-associated interstitial lung disease

Area of Science:

• Rheumatology
• Pulmonology
• Clinical Medicine

Background:

• Rheumatoid arthritis (RA) can lead to interstitial lung disease (ILD), a serious complication.
• Understanding pulmonary function trajectories in RA-ILD is crucial for patient management.

Purpose of the Study:

• To compare pulmonary function decline in RA-ILD patients.
• To investigate the impact of oral corticosteroid therapy on RA-ILD progression.
• To assess the influence of radiographic patterns on lung function in RA-ILD.

Main Methods:

• Retrospective analysis of 101 RA-ILD patients.
• Utilized a multiple regression model with time trends and random coefficients.
• Assessed changes in forced vital capacity (FVC) and diffusing capacity of the lungs for carbon monoxide (DLCO).

Main Results:

• Patients receiving corticosteroids had lower mean FVC and DLCO compared to untreated patients.
• The rate of FVC decline per 30 days was -0.10 in treated vs. -0.13 in untreated patients (p=0.571).
• The rate of DLCO decline per 30 days was -0.10 in both treated and untreated groups (p=0.985). Radiographic patterns did not alter results.

Conclusions:

• Pulmonary function decline rates were similar between corticosteroid-treated and untreated RA-ILD patients.
• Corticosteroid therapy did not significantly alter the rate of lung function decline in RA-ILD.
• Further research is needed to explore potential disease-modifying effects in RA-ILD.